glp-1 semaglutide weight loss treatments Treatment Specialist GLP-1 Medications for Weight Loss:

Introduction The development of new compounds in recent decades has substantially improved the pharmacotherapy of type 2 diabetes (T2D) by improving achievement of metabolic targets while mitigating specific side effects (e.g., weight gain, hypoglycemia) frequently observed in patients treated with traditional hypoglycemic drugs such as insulin and sulfonylureas

Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study

J Appl Nutr

[5] Neuromodulator [edit] GSSG, along with glutathione and S -nitrosoglutathione (GSNO), have been found to bind to the glutamate recognition site of the NMDA and AMPA receptors (via their -glutamyl moieties), and may be endogenous neuromodulators